Scientific advisory committee
The HRI Scientific Advisory Committee (SAC) is a team of independent world experts in homeopathy and Complementary and Alternative Medicine research, which provides the Institute with the strong scientific foundations essential to our work.
Members are appointed as independent scientific experts on the basis of their specific skills and knowledge. Individuals are required to declare any conflicts of interest.
As well as advising the charity on academic issues, SAC members provide a rigorous peer review process used to assess all incoming protocols, enabling us to confidently channel donations to the most promising research projects submitted to us.
The Committee enables HRI to operate with confidence, generating research of the highest quality and developing ever-stronger links throughout the international academic community.
Members of the Committee
Dr Stephan Baumgartner PhD
Lecturer, Institute of Complementary Medicine KIKOM, University of Bern and Senior Researcher, Society for Cancer Research, Arlesheim, Switzerland
Dr Baumgartner studied physics, mathematics and astronomy at the University of Basel (Switzerland). He has a PhD in Environmental Sciences from ETH Zurich (Switzerland). Stephan’s expertise is in basic research into homeopathy, with focus on the potentisation procedure (bioassays and physicochemical investigations). He is a founding member of The International Society of Complementary Medicine Research, founder of the Potentisation Research Group, and member of the GIRI (International Research Group on Very Low Dose and High Dilution Effects). Dr Baumgartner is currently a lecturer at the Institute of Complementary Medicine KIKOM, University of Bern, Switzerland, and senior researcher at the Society for Cancer research, Arlesheim, Switzerland.
Prof Dr Iris Bell MD PhD
Professor, Dept. of Family and Community Medicine, The University of Arizona College of Medicine, Tucson, Arizona, USA
Dr Bell has been a researcher in holistic and alternative medicine for over 30 years. She has served on the faculties at Harvard, UCSF and the University of Arizona. She is Board certified in Psychiatry, a fellow of the American College of Nutrition, nationally certified in biofeedback and licensed in homeopathy and integrated medicine in Arizona. Dr Bell has published papers and book chapters on her clinical research, a monograph on environmental illness and books for patients with anxiety disorders and chronic illness.
Prof Dr Paolo Bellavite
Professor of General Pathology, School of Medicine,
Verona University, Italy
Dr. Paolo Bellavite, is a medical doctor, teacher and researcher specialized in Clinical and Laboratory Haematology. He is specialized in Clinical and Laboratory Haematology. The main areas of research of Bellavite’s group focused on molecular and cellular aspects of inflammation, with particular regard to the structure, biochemistry and function (normal and pathological) of granulocytes (neutrophils and basophils), macrophages and platelets. He developed many micromethods in clinical laboratory to investigate pathophysiology and pharmacology of blood cells and free radicals. He carried out scientific research in the context of complementary therapeutic approaches and in particular of high dilutions of agonists and medicines on cellular and murine models.
Prof Dr Christian Endler
Head and Scientific Director, Interuniversity College for Health and Development Graz, Austria
Prof Endler’s research interests have included development of the amphibian model for in vitro investigation of the action of ultra high dilutions. He is a member of the Board of the International Group for Research on Infinitesimal Doses (GIRI).
Dr Peter Fisher MA MB BChir FRCP FFHom
Clinical Director and Director of Research, Royal London Hospital for Integrated Medicine, University College London Hospitals, NHS Trust
Dr Fisher is a graduate of Cambridge University and a Fellow of the Royal College of Physicians and the Faculty of Homeopathy. He currently holds the position of Clinical Director and Director of Research at the Royal London Hospital for Integrated Medicine and is Editor-in-Chief of the international journal, Homeopathy, published by Elsevier. He has been Physician to Her Majesty The Queen since 2001.
Dr Fisher chaired the World Health Organisation’s working group on homeopathy and is a member of WHO’s Expert Advisory Panel on Traditional and Complementary Medicine. He is also Clinical Lead of the UK’s National Library for Health’s on-line Complementary and Alternative Medicine Specialist Library, the NHS’s official knowledge website for Complementary and Alternative Medicine and of the Complementary and Alternative Medicine Library and Information service (CAMLIS).
Accredited as a specialist in both homeopathy and rheumatology, Dr Fisher has published many papers on research in homeopathy and other forms of complementary and alternative medicine.
Dr Jennifer Jacobs MD, MPH
Clinical Assistant Professor in Epidemiology, School of Public Health and Community Medicine, University of Washington
Prof Jacobs received her MD degree from Wayne State University and a Masters in Public Health at the University of Washington. She is a former President of the American Institute of Homeopathy, co-founded the special interest group of the American Public Health Association on Complementary and Alternative Health Practices, and served on the advisory board of the NIH Office of Alternative Medicine. In addition, she has published numerous homeopathic research studies in peer-reviewed medical journals. Now retired from medical practice, Dr. Jacobs continues to consult on homeopathic clinical research.
Dr Robert Mathie BSc PhD
Research Adviser, Homeopathy Research Institute
Dr Mathie studied Physiology at Glasgow University (UK). After receiving his PhD he moved on to the Department of Surgery at the Royal Postgraduate Medical School, London, where he became Senior Lecturer. Over a period of 25 years in the university sector, Dr Mathie published some 80 peer-reviewed papers and wrote many review articles and book chapters. Before joining HRI as Research Advisor, Dr Mathie held the post of Research Development Adviser at the British Homeopathic Association and Faculty of Homeopathy. Much of his work over 9 years was devoted to encouraging and assisting members of the Faculty to improve the quantity and the quality of research output in homeopathy. To this end, he developed collaborations with university researchers and led clinical data collection work with the Faculty’s doctors, dentists and vets. Within a broader aim to highlight and improve the nature and the quality of homeopathy research, Dr Mathie is currently engaged in a number of systematic reviews of published clinical trials.
Dr Clare Relton MSc PhD RSHom FFHom
Senior Research Fellow, School for Health and Related Research, University of Sheffield
Dr Relton originally studied Philosophy at the University of Newcastle upon Tyne (UK). She worked as a homeopath in the NHS 1998-2005 and was made Fellow of the Society of Homeopaths in 2009. She was awarded a Department of Health Pre Doctoral Training Fellowship from 2003 to 2008, obtained her MSc (Health Services Research) in 2004 and received her PhD (Clinical Trial Design) in 2009. Dr Relton is currently a research fellow at the School for Health and Related Research at the University of Sheffield. She is involved in research in obesity, chronic pain, IBS, and pragmatic clinical trial design.
Dr Elizabeth Thompson BAOxon MBBS MRCP FFHom
CEO & Homeopathic Consultant, Portland Centre for Integrative Medicine
Dr Thompson is a Consultant Homeopathic Physician specialising in oncology and a Fellow of the Faculty of Homeopathy. She previously held the post of Lead Clinician, Academic Director and Honorary Senior Lecturer in Palliative Medicine, at Bristol Homeopathic Hospital for many years. Dr Thompson now leads the team at the Portland Centre for Integrative Medicine in Bristol. Dr Thompson’s research interests have been around whether homeopathy can offer a novel approach to symptom control in the cancer patient and in particular managing side effects of cancer treatments. She also has an interest in trial design.
Dr Alexander Tournier BSc DIC MASt Cantab PhD LCHE RSHom
HRI Executive Director
Dr Tournier has a 1st class degree in Physics from Imperial College and a Master in Advanced Study in Theroretical Physics from Cambridge University. He wrote his PhD on the biophysics of water at the interface with biological molecules at the University of Heidelberg in Germany. Dr Tournier worked for 10 years at Cancer Research UK (5th institute worldwide for molecular biology) as a researcher working on problems at the interface between biology, physics and mathematics.